Hyperspectral Intelligence Platform
AI-powered hyperspectral imaging for real-time surgical guidance and tissue characterization
Platform · HybridCompany source
Company profile
About Hypervision Surgical
Hypervision Surgical Ltd is a King's College London spin-out founded by a team of clinicians, medical imaging and artificial intelligence experts. The company has developed a surgical imaging and data analytics platform that uses AI-powered hyperspectral imaging to make surgeries more precise, safer and faster. Their technology addresses a critical clinical need: providing surgeons with objective, real-time tissue information during operations to improve surgical precision and patient safety. The system uses safe light alone—no contrast agents required—to provide quantitative, wide-field information on physiological tissue properties including perfusion assessment and tissue differentiation. By splitting light into multiple spectral bands far beyond conventional RGB colours, their hyperspectral imaging carries diagnostic information ideal for objective tissue characterisation. The platform is capable of AI-driven, wide-field tissue differentiation to identify tumour, normal tissue, nerves and blood vessels in real time. This technology is particularly valuable in neurosurgery, where complete tumour removal must be balanced with healthy tissue preservation to minimise neurological impairment. The company's approach is non-contact, non-invasive, and seamlessly integrates into surgical workflow. Hypervision Surgical raised £6.5 million in seed funding in 2023 and appointed Martin Frost CBE, founder of CMR Surgical, as Chairman to accelerate commercialisation efforts.
Company description Hypervision Surgical official website
Primary marketSurgical AI & Robotics
Commercial modelCommercial information available on request
Company presenceOfficial website
Work at Hypervision Surgical?
Claim this listing Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Where the Company operates
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
Clinical focus
- Brain tumours
- Neurosurgery
- Skull base surgery
Who it serves
- Health Systems
- Hospitals
- Neurosurgery departments
Deployment & integration
Hybrid deployment with recorded integration context.
Geographic context
MarketsEurope · United Kingdom
Company sourceOfficial website
Company milestones
Platform expansion
Raised £6.5 million oversubscribed seed funding in June 2023. Appointed Martin Frost CBE (founder of CMR Surgical) as Chairman in September 2023. Presented technology at NVIDIA GTC 2022 keynote.
Partnerships
Recorded partners
- King's College Hospital
- King's College London
- Medtronic (via CSO's Research Chair)
- NVIDIA (technology presentation)
- Royal Academy of Engineering
02 · Flagship portfolio
Products, workflows, and platform capabilities
Selected source-backed Company products and the available commercial context.
03 · Research intelligence
Research Intelligence evidence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Evidence position
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
Publications & preprints
Hyperspectral abdominal laparoscopy with real-time quantitative tissue oxygenation imaging: a live porcine study.Frontiers in medical technology · Jan 1, 2025
Author response to: Comment on: Intraoperative bowel perfusion assessment methods and their effects on anastomotic leak rates: meta-analysis.The British journal of surgery · Jan 3, 2024
Deep Reinforcement Learning Based System for Intraoperative Hyperspectral Video Autofocusing.Medical image computing and computer-assisted intervention : MICCAI ... International Conference on Medical Image Computing and Computer-Assisted Intervention · Oct 1, 2023
Intraoperative bowel perfusion assessment methods and their effects on anastomotic leak rates: meta-analysis.The British journal of surgery · Aug 11, 2023
Rapid and robust endoscopic content area estimation: A lean GPU-based pipeline and curated benchmark dataset.Computer methods in biomechanics and biomedical engineering. Imaging & visualization · Jul 4, 2023
Synthetic white balancing for intra-operative hyperspectral imaging.Journal of medical imaging (Bellingham, Wash.) · Jul 1, 2023
Clinical validation
Clinical-trial records
No linked records are currently available.
Regulatory
Regulatory records
HyperSnap Surgical System (HSS)K250268 · 510k · Jun 24, 2025
04 · Company-reported outcomes
Outcomes and case studies
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
Improved surgical precision
Real-time tissue differentiation and characterisation
Increased patient safety
Objective tissue assessment without contrast agents
Complete tumour removal
Better visualisation for maximal resection while preserving healthy tissue
Reduced patient morbidity
Better intraoperative guidance across surgical specialties
IHU Strasbourg
In-vivo colorectal surgery study demonstrating real-time tissue analytics and dynamic tissue perfusion imaging with conventional laparoscopic components
Successfully revealed hidden tissue analytics insights invisible to the human eye during colorectal surgery procedures
05 · Leadership
Leadership team
Leadership profiles and professional links from the current Company record.
06 · Company updates
Updates from Hypervision Surgical
Recent articles published on Hypervision Surgical's official website.
Hypervision Surgical receives FDA Clearance for HYPERSNAP® Surgical System to improve patient safety
Read on Hypervision SurgicalHypervision Surgical Wins the Lippmann Award at IEEE WHISPERS Conference
Read on Hypervision SurgicalFrom Plenary Spotlight to Shark Tank Success: Hypervision Surgical at SRS 2025
Read on Hypervision Surgical07 · HAIC coverage
Coverage and analysis
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Company sources and channels
Curated official destinations from the active Company record.
09 · Market pathway
Additional Companies in this Market
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Surgical AI & Robotics
Companies developing surgical technologies enhanced by AI, including robotic surgical systems, AI-powered surgical assistance and navigation tools, autonomous surgical robotics, and surgical data and analytics platforms. Covers both the performance of surgery and the analysis of surgical outcomes and OR efficiency.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market
10 · Pro research
Coming soon
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Deeper Company research is coming soon.
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.